NCT06719973 2025-06-17
Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
EMD Serono
Phase 1 Withdrawn
EMD Serono
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Gilead Sciences
City of Hope Medical Center
Northwestern University
University of Pittsburgh
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute